164 related articles for article (PubMed ID: 33751795)
1. Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages.
Ferrari A; Iannó MF; Carenzo A; Fortunato O; Casanova M; Chiaravalli S; Bergamaschi L; Bertulli R; Cattaneo F; Collini P; Trama A; Sozzi G; Massimino M; De Cecco L; Gasparini P
Pediatr Blood Cancer; 2021 Jul; 68(7):e28987. PubMed ID: 33751795
[TBL] [Abstract][Full Text] [Related]
2. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
[TBL] [Abstract][Full Text] [Related]
3. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
[TBL] [Abstract][Full Text] [Related]
4. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
6. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
[TBL] [Abstract][Full Text] [Related]
7. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
9. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
[TBL] [Abstract][Full Text] [Related]
10. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond.
Chibon F; Lesluyes T; Valentin T; Le Guellec S
Genes Chromosomes Cancer; 2019 Feb; 58(2):124-129. PubMed ID: 30387235
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic studies in subgroups of rhabdomyosarcoma.
Whang-Peng J; Knutsen T; Theil K; Horowitz ME; Triche T
Genes Chromosomes Cancer; 1992 Nov; 5(4):299-310. PubMed ID: 1283318
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
13. MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults.
Casanova M; Pontis F; Ghidotti P; Petraroia I; Venturini LV; Bergamaschi L; Chiaravalli S; De Cecco L; Massimino M; Sozzi G; Ferrari A; Fortunato O; Gasparini P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430468
[TBL] [Abstract][Full Text] [Related]
14. Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead.
Van Gaal JC; De Bont ES; Kaal SE; Versleijen-Jonkers Y; van der Graaf WT
Crit Rev Oncol Hematol; 2012 Jun; 82(3):259-79. PubMed ID: 21802959
[TBL] [Abstract][Full Text] [Related]
15. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis.
Kilpatrick SE; Teot LA; Geisinger KR; Martin PL; Shumate DK; Zbieranski N; Russell GB; Fletcher CD
Cancer; 1994 Dec; 74(12):3227-33. PubMed ID: 7526971
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cyclin-dependent kinase inhibitors p16 and p57 in rhabdomyosarcoma.
Glumac S; Davidovic R; Dozic B; Hinic S; Pavlovic I; Drakulic D; Todorović A; Pavlovic MM; Skodric SR; Baralic I; Sopta J; Pejic S
Pathol Res Pract; 2021 Sep; 225():153558. PubMed ID: 34325314
[TBL] [Abstract][Full Text] [Related]
17. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.
Bertucci F; Niziers V; de Nonneville A; Finetti P; Mescam L; Mir O; Italiano A; Le Cesne A; Blay JY; Ceccarelli M; Bedognetti D; Birnbaum D; Mamessier E
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017155
[TBL] [Abstract][Full Text] [Related]
18. DNA content and proliferative activity in pediatric genitourinary rhabdomyosarcoma.
San Miguel-Fraile P; Carrillo-Gijón R; Rodríguez-Peralto JL; Ortiz-Rey JA; Alvarez-Alvarez C; de la Fuente-Buceta A
Pediatr Pathol Mol Med; 2003; 22(2):143-52. PubMed ID: 12556294
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
[TBL] [Abstract][Full Text] [Related]
20. Pediatric soft tissue sarcomas.
Loeb DM; Thornton K; Shokek O
Surg Clin North Am; 2008 Jun; 88(3):615-27, vii. PubMed ID: 18514702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
